Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical stage pharmaceutical company. The Company is engaged in the research and development of light, radiation, sound and/or drug-activated small molecule compounds, their associated drug formulations and the light systems that activate them, with a primary objective of efficacy and a secondary objective of safety in the destruction of various cancers, bacteria and viruses. It operates through two divisions: the Drug Division and the Device Division. The Drug Division is responsible for the research and development of light-activated small molecules primarily for the treatment of cancer with assistance from the Device Division to develop medical lasers to activate them. The Device Division is responsible for the Company’s medical laser business, which research, develops, manufactures and distributes cool laser therapy (CLT) systems to healthcare practitioners, predominantly for the healing of pain.

TSXV:TLT - Post by User

Theralase Technologies Inc. > New Press Release - Theralase Expands Intellectual Property Portfolio

<< Previous

Bullboard Posts

Next >>

Comment by ScienceFirston Jun 28, 2022 9:22am

233 Views

Post# 34786954

RE:RE:RE:RE:RE:New Press Release - Theralase Expands Intellectual Property Portfolio

Fully diluted, we stand @285M shares. TSO is 205M shares.

They clearly hinted us May 29 about pending data regarding 11 patients that had received their 2nd dose but that didn't have their cystoscopy yet @270-days. So 2 more months max to have all these 11 with 270-days data. In the meantime, if we could have data on 50% of those, that could be interesting.

<< Previous

Bullboard Posts

Next >>

Futures Flat Amid Key Data in Canada and US